Log in to save to my catalogue

Oligonucleotide therapies for disorders of the nervous system

Oligonucleotide therapies for disorders of the nervous system

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6043900

Oligonucleotide therapies for disorders of the nervous system

About this item

Full title

Oligonucleotide therapies for disorders of the nervous system

Publisher

New York: Nature Publishing Group US

Journal title

Nature biotechnology, 2017-03, Vol.35 (3), p.249-263

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Brain-targeted oligonucleotide-drugs are poised to treat multiple human central nervous system disorders with an emphasis on rare/orphan conditions.
Oligonucleotide therapies are currently experiencing a resurgence driven by advances in backbone chemistry and discoveries of novel therapeutic pathways that can be uniquely and efficiently modulate...

Alternative Titles

Full title

Oligonucleotide therapies for disorders of the nervous system

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6043900

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6043900

Other Identifiers

ISSN

1087-0156

E-ISSN

1546-1696

DOI

10.1038/nbt.3784

How to access this item